A universal culture medium for screening polymyxin-resistant gram-negative isolates

Journal of Clinical Microbiology

Volumn 54, Issue 5, 2016, Pages 1395-1399

  Nordmann, Patrice ^a,b   Jayol, Aurélie ^a   Poirel, Laurent ^a  

^a University of Fribourg   (Switzerland)

^b Hopital Cantonal de Fribourg   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; COLISTIN; DAPTOMYCIN; POLYMYXIN; ANTIINFECTIVE AGENT; CULTURE MEDIUM;

AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; GRAM NEGATIVE BACTERIUM; MICROBIAL MORPHOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STORAGE; SUPERPOLYMYXIN MEDIUM; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; MASS SCREENING; POLYMYXINS; SENSITIVITY AND SPECIFICITY;

EID: 84964956378     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00446-16     Document Type: Article

References (18)

1. Bialvaei AZ, Samadi Kafil H. 2015. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 31:707-721. http://dx.doi.org/10.1185 /03007995.2015.1018989.
2. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
3. Grasso GM, D'Errico MM, Schioppa F, Romano F, Montanaro D. 1988. Use of colistin and sorbitol for better isolation of Serratia marcescens in clinical samples. Epidemiol Infect 101:315-320. http://dx.doi.org/10.1017 /S0950268800054248.
4. Gilligan PH, Gage PA, Bradshaw LM, Schidlow DV, DeCicco BT. 1985. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 22:5-8.
5. Levine M. 1943. The effect of concentration of dyes on differentiation of enteric bacteria on eosin-methylene-blue agar. J Bacteriol 45:471-475.
6. Gordon NC, Png K, Wareham DW. 2010. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug- resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 54:5316-5322. http://dx.doi.org/10.1128/AAC.00922-10.
7. Randall CP, Mariner KR, Chopra I, O'Neill AJ. 2013. The target of daptomycin is absent from Escherichia coli and other Gram-negative pathogens. Antimicrob Agents Chemother 57:637-639. http://dx.doi.org /10.1128/AAC.02005-12.
8. Clinical and Laboratory Standards Institute. 2012. Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-9th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
10. EUCAST. 2014. Breakpoints tables for interpretation of MICs and zone diameters. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files /Breakpoint-tables/Breakpoint-table-v-4.0.pdf.
11. Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 53:3628-3634. http://dx.doi.org/10 .1128/AAC.00284-09.
12. Jayol A, Poirel L, Villegas MV, Nordmann P. 2015. Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca. Int J Antimicrob Agents 46:108-110. http://dx.doi.org/10.1016/j.ijantimicag .2015.02.015.
13. Lee JY, Ko KS. 2014. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis 78:271-276. http://dx.doi.org/10.1016/j .diagmicrobio.2013.11.027.
14. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Turkoglu S, Nordmann P. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70:75-80. http://dx.doi.org/10.1093/jac/dku323.
15. Quesada A, Porrero MC, Tellez S, Palomo G, Garcia M, Dominguez L. 2015. Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine. J Antimicrob Chemother 70:71-74. http://dx.doi.org/10.1093/jac /dku320.
16. Nordmann P, Girlich D, Poirel L. 2012. Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium. J Clin Microbiol 50:2761-2766. http://dx.doi.org/10.1128/JCM.06477-11.
17. Naas T, Ergani A, Carrër A, Nordmann P. 2011. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother 55:4038-4043. http://dx.doi.org/10.1128 /AAC.01734-10.
18. Froelich JM, Tran K, Wall D. 2006. A pmrA constitutive mutant sensitizes Escherichia coli to deoxycholic acid. J Bacteriol 188:1180-1183. http: //dx.doi.org/10.1128/JB.188.3.1180-1183.2006.